1. Binimetinib in heavily pretreated patients with NRAS‐mutant melanoma with brain metastases. (1st February 2020) Authors: Goldinger, S.M.; Valeska Matter, A.; Urner‐Bloch, U.; Narainsing, J.; Micaletto, S.; Blume, I.; Mangana, J.; Dummer, R. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Binimetinib in heavily pretreated patients with NRAS‐mutant melanoma with brain metastases. (9th October 2019) Authors: Goldinger, S.M.; Valeska Matter, A.; Urner‐Bloch, U.; Narainsing, J.; Micaletto, S.; Blume, I.; Mangana, J.; Dummer, R. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 488 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Crohn's disease: small bowel motility impairment correlates with inflammatory‐related markers C‐reactive protein and calprotectin. Issue 6 (18th March 2013) Authors: Bickelhaupt, S.; Pazahr, S.; Chuck, N.; Blume, I.; Froehlich, J. M.; Cattin, R.; Raible, S.; Bouquet, H.; Bill, U.; Rogler, G.; Frei, P.; Boss, A.; Patak, M. A Journal: Neurogastroenterology & motility Issue: Volume 25:Issue 6(2013:Jun.) Page Start: 467 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗